Interested to hear the latest in #PrecisionOncology? Hear from Dr. Kyle Strickland and Dr. Rebecca Previs as they discuss the different components of liquid biopsy and current technologies used to isolate circulating tumor cells (CTCs) and cell-free DNA (cfDNA). In this webinar, you will learn the potential clinical implications of liquid biopsies on molecular profiling of tumors for therapy selection, early detection of cancer, drug response and therapy resistance. Watch the video to learn more.
